Screening and treatment of chagas disease in organ transplant recipients in the United States: recommendations from the chagas in transplant working group.
about
Chagas disease and transfusion medicine: a perspective from non-endemic countriesScreening of living organ donors for endemic infections: Understanding the challenges and benefits of enhanced screening.Guidelines for the assessment and acceptance of potential brain-dead organ donors.Selecting suitable solid organ transplant donors: Reducing the risk of donor-transmitted infectionsTrypanosoma cruzi and Chagas' Disease in the United StatesChagas heart disease: report on recent developments.Use of a Chagas Urine Nanoparticle Test (Chunap) to Correlate with Parasitemia Levels in T. cruzi/HIV Co-infected Patients.Benznidazole Extended-Release Tablets for Improved Treatment of Chagas Disease: Preclinical Pharmacokinetic Study.Safety of liver transplantation with Chagas disease-seropositive donors for seronegative recipients.Donor-derived infection: epidemiology and outcomes.Update on donor-derived infections in liver transplantation.Reactivation of Chagas disease in a bone marrow transplant patient: case report and review of screening and management.An approach to the management of Trypanosoma cruzi infection (Chagas' disease) in immunocompromised patients.Molecular diagnosis in clinical parasitology: when and why?Donor-derived infection--the challenge for transplant safety.A Case of Possible Chagas Transmission by Blood Transfusion in SwitzerlandTransplantation in the tropics: lessons on prevention and management of tropical infectious diseases.KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors.Infectious Complications After Liver Transplantation.Heart transplant recipient with history of Chagas disease and elevated panel-reactive antibodies.Chagas disease in non-endemic countries: epidemiology, clinical presentation and treatment.Transmission of Donor-Derived Trypanosoma cruzi and Subsequent Development of Chagas Disease in a Lung Transplant Recipient.Chagas disease and liver transplantation: Experience in Argentina using real-time quantitative PCR for early detection and treatment.Considerations for screening live kidney donors for endemic infections: a viewpoint on the UNOS policy.Seroprevalence of Trypanosoma cruzi in kidney transplant donors and recipients in Mexico City.Parasitic infections in solid organ transplantation.Donor-derived infections in solid organ transplantation.Screening of donor and recipient in solid organ transplantation.Chagas disease in Australia and New Zealand: risks and needs for public health interventions.Heart transplantation for Chagas cardiomyopathy in the United States.Results of lookback for Chagas disease since the inception of donor screening at New York Blood Center.Is it safe to use a liver graft from a Chagas disease-seropositive donor in a human immunodeficiency virus-positive recipient? A case report addressing a novel challenge in liver transplantation.Donor-derived Trypanosoma cruzi infection in solid organ recipients in the United States, 2001-2011.Liver transplantation using Chagas-infected donors in uninfected recipients: a single-center experience without prophylactic therapy.An autopsy-based study of Trypanosoma cruzi persistence in organs of chronic chagasic patients and its relevance for transplantation.Evaluation of the Elecsys® Chagas Assay for the Detection of Trypanosoma cruzi-Specific Antibodies in a Multicenter Study in Europe and Latin America.Prevalence of Chagas Disease among Solid Organ-Transplanted Patients in a Nonendemic Country.Chagas disease in transplantation: time to enter an era of better diagnosis and better outcomes.An unusual case of congestive heart failure in the Netherlands.
P2860
Q26777968-9243F7E2-9B12-444A-AE43-DC3FB311BBB6Q30241036-4EF42862-2E6E-4D15-9ADE-0FCED2303D38Q30372798-1D9FE800-0789-42AB-BF80-BC7319844F0EQ33891744-9B845611-3600-48CC-9F31-CE841125E881Q35361594-E8F4B040-22BE-49EC-8177-15234728EA46Q35745413-F646D6F3-8EF3-4D44-8EE8-E5F70B19A5DFQ35937351-25E30D08-F70B-4359-AD4D-08FB38300DBDQ36729990-2B2D00EE-1ED8-46BC-B29D-2CCB617E48EAQ37880745-2E6C35BB-412D-49D7-B5E3-A34BBF0126E2Q38052820-0284C1AB-3321-4D4C-8270-CA1E1DF637D8Q38092789-B03D60D2-181C-4692-B312-AF46F078E2EFQ38154667-40424FFC-E1BB-42DD-8899-0DA1301672A1Q38183905-5AA764EA-5FDD-4EA7-AC30-FEED8494103CQ38199443-93032C27-7286-4126-93AA-49E01AC13CEFQ38245354-EC30B4A1-D7AC-41F1-A1CF-101D50AE68B4Q38376720-94C8EB3A-1B05-4170-B229-77962BDD500CQ38511222-C7797B88-EBC0-4AE5-9B36-E3B00E2F6638Q38652031-96B62B42-6355-4A91-9E0A-46139CC8E719Q38822708-B4937D1E-4F84-46E1-9573-3DC1C38D026BQ38934309-D483686E-974B-429B-9045-B7C7C3656056Q39372756-13C361A4-0C34-4126-BF79-010C766E9E6EQ40044742-BB187A94-F84E-409E-934A-C1D64693A6D0Q41994913-5D8F2F58-00C0-4EF8-93EB-E97C1A7EFD56Q42223657-A7EBF033-4720-443E-B9A3-FECA683C737EQ42253066-33227FD1-F7DF-4B9C-8EF9-105B2E138C29Q42272278-6C6EB1F7-1A34-4753-9D15-E03F9D4CC0ADQ42272362-FE15F3EC-0844-4271-8F2E-25C15ED3EB7FQ42272365-71EBBAF7-A3E9-47E3-BEEE-8EF0C3737895Q43412051-3B25B446-181F-4A59-A8E0-3F109C1D754DQ44298307-C1228983-593D-430D-909B-46073C398C6DQ44672899-30534671-1BCC-4625-9E23-93A3358D70CAQ45358293-A8B92C77-05FA-4AA4-8D42-69DE051C97AAQ45835999-4B9A8C4A-32CC-4F6B-BD0F-2FAF356E871AQ46449485-51389C3D-4CF4-4543-955E-0D82A8EF30B8Q49848843-DE546D84-004C-47FD-B6F6-104AB7E569A3Q50042300-36A1A1AA-90D0-4210-B305-0E558364004EQ50192396-1960187F-6D8B-4D89-8D79-9DF0C4EC5F34Q51858330-F8EE2105-F298-4352-BFC2-A1E0A3D5F25BQ54954834-700B879E-38FE-4606-968A-3C5103E86EC8
P2860
Screening and treatment of chagas disease in organ transplant recipients in the United States: recommendations from the chagas in transplant working group.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 March 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Screening and treatment of cha ...... s in transplant working group.
@en
Screening and treatment of cha ...... s in transplant working group.
@nl
type
label
Screening and treatment of cha ...... s in transplant working group.
@en
Screening and treatment of cha ...... s in transplant working group.
@nl
prefLabel
Screening and treatment of cha ...... s in transplant working group.
@en
Screening and treatment of cha ...... s in transplant working group.
@nl
P2093
P2860
P1476
Screening and treatment of cha ...... s in transplant working group.
@en
P2093
B S Schwartz
M I Morris
P V Chin-Hong
S P Montgomery
P2860
P304
P356
10.1111/J.1600-6143.2011.03444.X
P407
P50
P577
2011-03-14T00:00:00Z